A citation-based method for searching scientific literature

Birgit Janssens, Simon Caerels, Chantal Mathieu. Ther Adv Endocrinol Metab 2020
Times Cited: 9







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
155
44

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
883
33

Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study.
Torben Biester, Ido Muller, Thekla von dem Berge, Eran Atlas, Revital Nimri, Moshe Phillip, Tadej Battelino, Natasa Bratina, Klemen Dovc, Markus F Scheerer,[...]. Diabetes Obes Metab 2021
23
33

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
33

Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
Francesco Zaccardi, David R Webb, Thomas Yates, Melanie J Davies. Postgrad Med J 2016
244
22


A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Ahmad Haidar, Michael A Tsoukas, Sarah Bernier-Twardy, Jean-Francois Yale, Joanna Rutkowski, Anne Bossy, Evelyne Pytka, Anas El Fathi, Natalia Strauss, Laurent Legault. Diabetes Care 2020
59
22


Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Jennifer L Sherr, Neha S Patel, Camille I Michaud, Miladys M Palau-Collazo, Michelle A Van Name, William V Tamborlane, Eda Cengiz, Lori R Carria, Eileen M Tichy, Stuart A Weinzimer. Diabetes Care 2016
54
22


Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2.
Chantal Mathieu, Paresh Dandona, Andreas L Birkenfeld, Troels Krarup Hansen, Nayyar Iqbal, John Xu, Enrico Repetto, Markus Florian Scheerer, Fredrik Thoren, Moshe Phillip. Diabetes Obes Metab 2020
16
22

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
64
22


Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.
Ruth S Weinstock, Dongyuan Xing, David M Maahs, Aaron Michels, Michael R Rickels, Anne L Peters, Richard M Bergenstal, Breanne Harris, Stephanie N Dubose, Kellee M Miller,[...]. J Clin Endocrinol Metab 2013
219
22

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
22



HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.
Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A Kushner, Pablo Lapuerta, Darren K McGuire, Anne L Peters,[...]. Diabetes Care 2018
98
22

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2018
117
22

Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial.
Chantal Mathieu, Gottfried Rudofsky, Moshe Phillip, Eiichi Araki, Marcus Lind, Niki Arya, Fredrik Thorén, Markus F Scheerer, Nayyar Iqbal, Paresh Dandona. Diabetes Obes Metab 2020
27
22

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
22

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
22

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
22

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
149
22

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
231
22

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
479
22

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
22

SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
Erik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, Mark H H Kramer, Max Nieuwdorp, Daniel H van Raalte. Clin J Am Soc Nephrol 2017
112
22

Role of RalA downstream of Rac1 in insulin-dependent glucose uptake in muscle cells.
Shinsuke Nozaki, Shuji Ueda, Nobuyuki Takenaka, Tohru Kataoka, Takaya Satoh. Cell Signal 2012
35
11

In vitro α-amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of Citrus macroptera Montr. fruit.
Nizam Uddin, Md Rakib Hasan, Md Monir Hossain, Arjyabrata Sarker, A H M Nazmul Hasan, A F M Mahmudul Islam, Mohd Motaher H Chowdhury, Md Sohel Rana. Asian Pac J Trop Biomed 2014
38
11

Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
Dareen A Youssef, Hassan M El-Fayoumi, Mona F Mahmoud. Biomed Pharmacother 2019
40
11

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Shivakumar Chitturi, Shehan Abeygunasekera, Geoffrey C Farrell, Jane Holmes-Walker, Jason M Hui, Caroline Fung, Rooshdiya Karim, Rita Lin, Dev Samarasinghe, Christopher Liddle,[...]. Hepatology 2002
859
11

Meroterpene-Like α-Glucosidase Inhibitors Based on Biomimetic Reactions Starting from β-Caryophyllene.
Da-Wei Yan, Cheng-Di Huang, Hang-Hang Zheng, Na Zhao, Xiao-Lan Feng, Shuang-Jiang Ma, An-Ling Zhang, Qiang Zhang. Molecules 2020
4
25

Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome.
Christian K Roberts, R James Barnard, Ram K Sindhu, Michael Jurczak, Ashkan Ehdaie, Nosratola D Vaziri. Metabolism 2006
236
11

Ferulago nodosa Subsp. geniculata (Guss.) Troia & Raimondo from Sicily (Italy): Isolation of Essential Oil and Evaluation of Its Bioactivity.
Natale Badalamenti, Vincenzo Ilardi, Sergio Rosselli, Maurizio Bruno, Filippo Maggi, Mariarosaria Leporini, Tiziana Falco, Monica R Loizzo, Rosa Tundis. Molecules 2020
16
11

Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice.
George Laylson da Silva Oliveira, Keylla Conceição Machado, Kátia Conceição Machado, Ana Paula Dos Santos C L da Silva, Chistiane Mendes Feitosa, Fernanda Regina de Castro Almeida. Regul Toxicol Pharmacol 2018
33
11


Role of the endocannabinoid system in diabetes and diabetic complications.
G Gruden, F Barutta, G Kunos, P Pacher. Br J Pharmacol 2016
93
11

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
Bėla Horváth, Lital Magid, Partha Mukhopadhyay, Sándor Bátkai, Mohanraj Rajesh, Ogyi Park, Galin Tanchian, Rachel Y Gao, Catherine E Goodfellow, Michelle Glass,[...]. Br J Pharmacol 2012
82
11

Rapid prediction and identification of lipase inhibitors in volatile oil from Pinus massoniana L. needles.
Miao Wang, Dongyu Gu, Haoquan Li, Qi Wang, Jie Kang, Tingting Chu, Hong Guo, Yi Yang, Jing Tian. Phytochemistry 2017
8
12



Nonalcoholic fatty liver disease.
Paul Angulo. N Engl J Med 2002
11

AMPK: a nutrient and energy sensor that maintains energy homeostasis.
D Grahame Hardie, Fiona A Ross, Simon A Hawley. Nat Rev Mol Cell Biol 2012
11

Small G proteins in islet beta-cell function.
Anjaneyulu Kowluru. Endocr Rev 2010
102
11

Impact of functional foods on prevention of cardiovascular disease and diabetes.
Geeta Sikand, Penny Kris-Etherton, Nancy Mariam Boulos. Curr Cardiol Rep 2015
35
11

Flavonoids and Terpenoids with PTP-1B Inhibitory Properties from the Infusion of Salvia amarissima Ortega.
Eric Salinas-Arellano, Araceli Pérez-Vásquez, Isabel Rivero-Cruz, Rafael Torres-Colin, Martín González-Andrade, Manuel Rangel-Grimaldo, Rachel Mata. Molecules 2020
8
12

Protective effects of combined β-caryophyllene and silymarin against ketoprofen-induced hepatotoxicity in rats.
Mohamed Elsayed Kelany, Mohamed Abdelmohsen Abdallah. Can J Physiol Pharmacol 2016
8
12

Dietary administration of β-caryophyllene and its epoxide to Sprague-Dawley rats for 90 days.
Maria Bastaki, Anne Marie Api, Michel Aubanel, Mark Bauter, Thierry Cachet, Jan C R Demyttenaere, Maodo Malick Diop, Christie L Harman, Shim-Mo Hayashi, Gerhard Krammer,[...]. Food Chem Toxicol 2020
11
11

Functionalization of β-caryophyllene generates novel polypharmacology in the endocannabinoid system.
Andrea Chicca, Diego Caprioglio, Alberto Minassi, Vanessa Petrucci, Giovanni Appendino, Orazio Taglialatela-Scafati, Jürg Gertsch. ACS Chem Biol 2014
50
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.